Ann: Viralytics to Present New CAVATAK Clinical Data at AACR, page-7

  1. 13,164 Posts.
    lightbulb Created with Sketch. 1214
    Hi Bripoz,
    Lets hope this presentation can clinch us a deal or lead to a crack at a phase 3 approval or bloody something.
    We need some direction or we are always in the sights of the traders.
    Nice claw back today but by rights we should be around the $1 2o mark imo.
    Aloha.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.